Radiotherapy also upregulates the expression of CXCL9 and CXCL10 TDLNs, facilitating the recruitment of effector T cells and natural killer (NK) cells, and enhancing immune recognition and clearance of tumor cells (77). Here, CXCL9 is linked to neoplasm.